Levophed(r) Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 51662-1315

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levophed(r) Norepinephrine Bitartrate (NDC 51662-1315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Label (51662131527 Levophed Pouch Label)

Label for Levophed (norepinephrine bitartrate) injection USP, 4 mg/4 mL in a 4 mL vial. The label includes NDC 51662-1315-2, lot number 300930, and an expiration date of 2030-09-30. Warning information and manufacturer details (HF Acquisition Co LLC, Mukilteo, WA) are partially visible.*

FDA Label Image

Case Labeling (51662131534 Levophed Case Label)

Label for LEVOPHED(R) Norepinephrine Bitartrate Injection, USP 4 mg/4 mL solution in a 4 mL vial, packaged as a box of 10. The label includes NDC 51662-1315-3, lot number 12345, and an expiration date of 09/30/2030. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. The label also contains storage, handling, and safety warnings, and a QR code.*

FDA Label Image

Rfid Label (51662131534 Levophed Rfid Label)

Data matrix barcode label for LEVOPHED(R) NOREPINEPHRINE BITARTRATE injection, solution, concentrate 1 mg/mL, distributed by HF Acquisition Co LLC, Mukilteo, WA. The label includes product identifiers, a lot number, and an expiration date, with text stating 'See manufacturer's package insert' and 'RX ONLY.'*

FDA Label Image

How Supplied (How Supplied)

A table presenting the unit of sale and concentration for a drug product, showing an NDC code 0409-3375-04 with a concentration of 4 mg/4 mL, and packaging as 10 units in a carton with 1 mg/mL concentration.*

FDA Label Image

Logo (Logo)

FDA Label Image

Carton (Levophed 0409 3375 14 Carton)

Packaging label for Levophed (norepinephrine bitartrate) injection, USP 4 mg/4 mL (1 mg/mL) sterile concentrate for intravenous use. The label indicates 10 single-dose fliptop vials, NDC 0409-3375-04, distributed by Hospira and includes warnings about dosage control and storage instructions. The label is printed with green and black text on a white background.*

FDA Label Image

Vial (Levophed 0409 3375 14)

Label for Levophed (norepinephrine bitartrate) injection, USP 4 mg/4 mL (1 mg/mL) concentrate for intravenous infusion. The single-dose fliptop vial contains 4 mL fill in a 5 mL vial. The label includes a warning for sulfites and instructions to dilute before use, with storage instructions to protect from light. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Precautions (Precautions)

A drug facts text panel providing instructions for treating extravasation ischemia caused by LEVOPHED (norepinephrine bitartrate). It details the use of phentolamine (Regitine) as an antidote to prevent tissue necrosis, including dosage and method of infiltration, emphasizing timely administration within 12 hours.*

FDA Label Image

Serialized Label (Serialized Label)

A small brown glass vial with a green cap labeled Levophed norepinephrine injection, USP, concentrated solution for IV infusion. The partial label includes information about the active ingredient norepinephrine bitartrate, dosage instructions, and the distributor HF Acquisition Co LLC. A barcode label with numeric codes is also visible beside the vial.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of levophed (norepinephrine bitartrate) showing the molecular arrangement of norepinephrine combined with the bitartrate and water components.*

FDA Label Image

Vial Label (Vial Label)

Label for Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1 mg/mL) single dose fliptop vial. The 4 mL fill in a 5 mL vial is for intravenous infusion only. The label includes warnings for sulfites and protection from light. Manufactured by Hospira, Inc., Lake Forest, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.